Tech Center 1600 • Art Units: 1614 1629 1652
This examiner grants 84% of resolved cases
Raymond J. Henley III is an experienced examiner in Art Unit 1614, part of Tech Center 1600. With 1258 resolved cases, his profile offers a very robust data set for analysis. He maintains a high allowance rate of 83.5 percent. This suggests that he is very open to finding allowable subject matter, making him a favorable examiner for applicants. The 1258 resolved cases establish a reliable baseline for predicting outcomes in Art Unit 1614.
The interview lift for this examiner is a modest 2.3 percent. Given that his baseline allowance rate is already 83.5 percent, the small lift suggests that interviews have a minimal impact on the overall probability of success. While an interview may still be useful for clarifying specific points, it is not as critical a tool as it is with other examiners. Practitioners can feel confident in the high baseline success rate even without an interview in Tech Center 1600.
In terms of efficiency, the median days to allowance is 693. This is an impressively fast timeline, indicating a very streamlined prosecution process. The combination of an 83.5 percent allowance rate and a 693-day median pendency makes for an ideal prosecution experience. Applicants can use these metrics from his 1258 resolved cases to set very positive expectations for their own applications. The 693-day duration is a key benchmark for efficiency.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19572691 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19572667 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19569963 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Final Rejection | Veradermics, Incorporated |
| 19570012 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19569918 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Final Rejection | Veradermics, Incorporated |
| 19546276 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19542655 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19539689 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19538689 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19538745 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19444686 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19443936 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19442911 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19442899 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19442979 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19442974 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19441484 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19436869 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19430093 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19420555 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19402812 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19329494 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Final Rejection | Veradermics, Incorporated |
| 19329476 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Final Rejection | Veradermics, Incorporated |
| 19328077 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Final Rejection | Veradermics, Incorporated |
| 19308124 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Final Rejection | Veradermics, Incorporated |
| 19267447 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19267464 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19260035 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19258817 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19253703 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Final Rejection | Veradermics, Incorporated |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy